Abstract
An association has recently been proposed between seizure promotion and consumption of the phenylalanine-containing artificial sweetener aspartame. Since consumption of aspartame, unlike dietary protein, can elevate brain phenylalanine, and thus potentially inhibit the synthesis and release of neurotransmitters known to protect against seizure activity, we have studied the effects of aspartame and of its metabolic breakdown products (aspartic acid, methanol, and phenylalanine) on seizure activity, using two well-established experimental models, i.e., pen-tylenetetrazole and fluorothyl-induced seizures. The doses employed were chosen to produce changes in the plasma phenylalanine ratio which would mimic, in the mouse, the changes seen when humans consume moderate amounts of the sweetener. Mice receiving aspartame in doses of 1000 mg/kg or greater exhibited a significant lowering in the threshold to seizures induced by pentylenetetrazole. This response was mimicked by equimolar phenylalanine, but not by equimolar aspartic acid or methanol. Additionally, we tested the ability of tyrosine, a precursor of seizure-protecting catecholamines, to influence pentylenetetrazole-induced seizures. Tyrosine doses of 500 mg/kg or greater significantly elevated the seizure threshold in this model. Coadministration of tyrosine with either phenylalanine or aspartame prevented the deleterious effects of these compounds on the seizure threshold. Similarly, coadministration of the large neutral amino acid valine, which competes with phenylalanine for entry into the brain, also prevented the phenylalanine-induced changes. When phenylalanine or aspartame were administered prior to fluorothyl exposure, a significant decrease in the seizure threshold was also noted. Doses as low as 500 mg/kg were able to potentiate these seizures in immature mice. We conclude that in these commonly employed seizure models, aspartame, via its metabolic breakdown product phenylalanine, is capable of lowering the threshold to seizures. This may bear on the reported association between aspartame and seizures in humans.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Altman, I.M., and Corcoran, M.E. (1983). Facilitation of neocortical kindling by depletion of forebrain noradrenaline. Brain Res. 270:174–177.
Altshuler, H.J., Killam, E.K., and Killam, K.F. (1976). Biogenic amines and the photomyoclonic syndrome in the baboon Papio papio. J. Pharmacol. Exp. Ther. 196:156–166.
Araki, H., Aihara, H., Watanabe, S., Ohta, H., Yamamoto, T., and Ueki, S. (1983). The role of noradrenergic and serotonergic systems in the hippocampal kindling effect. Jpn. J. Pharmacol. 33:57–64
Arnold, P., Racine, R., and Wise, R. (1973). Effect of atropine, reserpine, 6-hydroxydopamine, and handling on seizure development in the rat. Exp. Neurol. 40:457–460.
Boggan, W.O., and Seiden, L.S. (1971). Dopa reversal of reserpine enhancement of audiogenic seizure susceptibility in mice. Physiol. Behav. 6:215–217.
Caballero, B., Mahon, B., Rohr, F., Levy, H., and Wurtman, R.J. (1986). Plasma amino acid levels after single dose aspartame consumption in phenylketonuria. J. Pediatr. 109:668–671.
Centers for Disease Control. (1984). Evaluation of consumer complaints related to aspartame use. Morb. Mortal. Weekly Rep. 33:605–607.
Chen, G., Ensor, C.R., and Bohner, B. (1968). Studies on drug effects on electrically induced extensor seizures and clinical implications. Arch. Int. Pharma-codyn. 172:183–218
Conlay, L.C., Maher, T.J. and Wurtman, R.J. (1981). Tyrosine increases blood pressure in hypotensive rats. Science 212:559–560.
Corcoran, M.E., and Mason, S.T. (1980). Role of forebrain catecholamines in amygdaloid kindling. Brain Res. 190:473–484.
Dailey, J.W., and Jobe, P.C. (1984). Effects of increments in the concentration of dopamine in the central nervous system on audiogenic seizures in DBA/2J mice. Neuropharmacology 23:1019–1024.
Drake, M.E. (1986). Panic attacks and excessive aspartame ingestion. Lancet ii:631.
Ferguson, J.M. (1985). Interaction of aspartame and carbohydrates in an eating disorder patient. Am. J. Psychiatr. 142:271.
Fernstrom, M.H., Volk, E.A., and Fernstrom, J.D. (1984). In vivo tyrosine hydroxylation in the diabetic rat retina: effect of tyrosine administration. Brain Res. 298:167–170.
Gallagher, B.B. (1969). Amino acids and cerebral excitability. J. Neurochem. 16:701–706.
Garattini, S. (1986). Aspartame, brain monoamines and neurochemical mediators. International Aspartame Workshop, November, Marbella, Spain.
Jobe, P.C., Picchioni, A.L., and Chin, L. (1973). Effect of lithium carbonate and alpha-methyl-p-tyrosine on audiogenic seizure intensity. J. Pharm. Pharmacol. 25:830–831.
Jobe, P.C., Ko, K.H., and Dailey, J.W. (1984). Abnormalities in norepinephrine turnover rate in the central nervous system of the genetically epilepsy-prone rat. Brain Res. 290:357–360.
Jobe, P.C., Dailey, J.W., and Reigel, C.E. (1986). Noradrenergic and serotonergic determinants of seizure susceptibility and severity in genetically epilepsy-prone rats. Life Sci. 39:775–782.
Johns, D.R. (1986): Migraine provoked by aspartame. N. Engl. J. Med. 315:456.
Kilian, M., and Frey, H.H. (1973). Central monoamines and convulsive thresholds in mice and rats. Neuropharmacology 12:681–692.
Kim, K.C., and Kim, S.H. (1987). Studies on the effect of aspartame and lidocaine interaction in central nervous system of mice. Fed. Proc. 46:705.
Kiritsy, P.J., and Maher, T.J. (1986). Acute effects of aspartame on systolic blood pressure in spontaneously hypertensive rats. J. Neural Transm. 66:121–128.
Kleinrok, Z., Czuczwar, S., Wojcik, A., and Przegalinski, E. (1978). Brain dopamine and seizure susceptibility in mice. Pol. J. Pharmacol. Pharm. 30:513–519.
Lehnert, H., Reinstein, D.K., Trowbridge, B.W., and Wurtman, R.J. (1984). Neurochemical and behavior consequences of acute, uncontrollable stress: effect of dietary tyrosine. Brain Res. 303:215–223.
Lewis, J., Westerberg, V., and Corcoran, M.E. (1987). Monoaminergic correlates of kindling. Brain Res. 403:205–212.
Litchfield, J.T. Jr., and Wilcoxon, F. (1949). A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96:99–113.
Mclntyre, D.C., and Edson, N. (1981). Facilitation of amygdaloid kindling after norepinephrine depletion with 6-hydroxydopamine in rats. Exp. Neurol. 74:748–757.
McKenzie, G.M., and Soroko, F.E. (1972). The effects of apomorphine, (+)-amphetamine and L-dopa on maximal electroshock convulsions—a comparative study in the rat and mouse. J. Pharm. Pharmacol. 24:696–701.
McKenzie, G.M., and Soroko, F.E. (1973). Inhibition of the anticonvulsant activity of L-dopa by FLA-63, a dopamine-beta-hydroxylase inhibitor. J. Pharm. Pharmacol. 25:76–77.
Melamed, E., Hefti, F., and Wurtman, R.J. (1980). Tyrosine administration increases striatal dopamine release in rats with partial nigrostriatal lesions. Proc. Natl. Acad. Sci. USA 77:4305–4309.
Milner, J.D., Irie, K., and Wurtman, R.J. (1986). Effects of phenylalanine on the release of endogenous dopamine from rat striatal slices. J. Neurochem. 47:1444–1448.
Nagatsu, T., Levitt, M., and Udenfriend, S. (1964). Tyrosine hydroxylase, the initial step in norepinephrine biosynthesis. J. Biol. Chem. 239:2910–2917.
Pinto, J.M.B. and Maher, T.J. (1988). Aspartame administration potentiates fluorothyl-and pentylenetetrazole-induced seizure in mice. Neuropharmacol. 27:51–55.
Rudzik, A.D., and Johnson, G.A. (1970). Effect of amphetamine and amphetamine analogs on convulsive thresholds. In Costa, E., and Garratini, S. (eds.), Amphetamines and related compounds. New York: Raven Press, p. 715.
Schlesinger, K., Boggan, W., and Freedman, D.X. (1968). Genetics of audiogenic seizures. II. Effects of pharmacological manipulation of brain serotonin, norepinephrine and gamma-aminobutyric acid. Life Sci. 7:437–447
Sved, A.F., Fernstrom, J.D., and Wurtman, R.J. (1979). Tyrosine administration reduces blood pressure and enhances brain norepinephrine release in spontaneously-hypertensive rats. Proc. Natl. Acad. Sci. USA 76:3511–3514.
Thakore, K., and Crane, S.C. (1987). Blood pressure and regional brain tyrosine, norepinephrine and dopamine in spontaneously hypertensive rats fed aspartame or sucrose. Fed. Proc. 46:904.
Walton, R.G. (1986). Seizure and mania after high intake of aspartame. Psycho-somatics 27:218–220.
Wurtman, R.J. (1985). Aspartame: possible effect on seizure susceptibility. Lancet ii:1060.
Yokogoshi, H., and Wurtman, R.J. (1986). Acute effects of oral or parenteral aspartame on catecholamine metabolism in various regions of rat brain. J. Nutr. 116:356–364.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Birkhäuser Boston
About this chapter
Cite this chapter
Pinto, J.M.B., Maher, T.J. (1988). Aspartame, Phenylalanine, and Seizures in Experimental Animals. In: Wurtman, R.J., Ritter-Walker, E. (eds) Dietary Phenylalanine and Brain Function. Birkhäuser Boston. https://doi.org/10.1007/978-1-4615-9821-3_10
Download citation
DOI: https://doi.org/10.1007/978-1-4615-9821-3_10
Publisher Name: Birkhäuser Boston
Print ISBN: 978-1-4615-9823-7
Online ISBN: 978-1-4615-9821-3
eBook Packages: Springer Book Archive